I get what you're saying, but given all of those t
Post# of 145753
Granted, CYDY is barely a company, with what, 7 employees or so? They clearly have to outsource everything, so while it would appear that a partnership or BO is a must, again, I just wonder if the money for a BO is really possible given the financial potential here.
What do you see as financially acceptable for a BO if we do get BTD for breast cancer, the basket trial, and approval for combo HIV (knowing that approval for mono wouldn't be far off either)? This of course doesn't even touch on BTD for GvHD and also a NASH partnership which NP mentioned within a year. The Vyera deal could hamstring us a bit too...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)